Table 2 Comparison of the means of VβTCR expression in a topic cohort with healthy control from McLean-Tooke et al. study
0–2 years n = 16 Gassem g et al. | 0–9 months n = 5 McLean-Tooke et al. | 3–6 years n = 12 Gassem g et al. | 2–5 years n = 10 McLean-Tooke et al. | 7–18 n = 25 Gassem g et al. | 10–16 n = 10 McLean-Tooke et al. | |
|---|---|---|---|---|---|---|
Vβ_1 | 3.5 | 3.6 | 3.6 | 3·9 | 3.6 | 4.0 |
Vβ_2 | 9.5 | 9.9 | 8.8 | 8·8 | 7.6 | 8.7 |
Vβ_3 | 4.9 | 5.7 | 4.1 | 4·9 | 3.5 | 3.7 |
Vβ_4 | 2.1 | 2.1 | 2.0 | 2·1 | 2.2 | 2.2 |
Vβ_5.2 | 1.7 | 1.3 | 1.7 | 1·7 | 2.2 | 1.6 |
Vβ_5.3 | 1.3 | 0.73 | 1.3 | 1·2 | 1.1 | 1.0 |
Vβ_7.1 | 2.9 | 2.7 | 2.5 | 2·6 | 2.6 | 2.7 |
Vβ_7.2 | 1.0 | 1.0 | 1.2 | 1·5 | 1.0 | 1.6 |
Vβ_8 | 5.4 | 4.5 | 5.4 | 5·4 | 5.2 | 5.2 |
Vβ_9 | 2.2 | 2.9 | 1.8 | 3·3 | 2.1 | 3.4 |
Vβ_11 | 1.3 | 0.9 | 1.1 | 1·0 | 1.3 | 1.0 |
Vβ_12 | 1.6 | 1.6 | 1.7 | 1·8 | 1.6 | 1.7 |
Vβ_13_1 | 3.7 | 4.5 | 4.3 | 5·0 | 3.6 | 4.5 |
Vβ_13_2 | 2.4 | 3.1 | 2.9 | 3·5 | 2.8 | 4.0 |
Vβ_13.6 | 1.8 | 1.8 | 1.6 | 1·8 | 1.5 | 1.8 |
Vβ_14 | 3.6 | 4.5 | 3.5 | 4·5 | 4.0 | 4.0 |
Vβ_16 | 1.0 | 1.2 | 1.0 | 0·9 | 1.0 | 1.1 |
Vβ_17 | 5.0 | 5.1 | 4.7 | 5·7 | 5.0 | 5.4 |
Vβ_21.3 | 2.5 | 2.5 | 2.3 | 2·5 | 2.3 | 2.5 |
Vβ_22 | 3.8 | 3.0 | 3.4 | 3·57 | 3.6 | 3.6 |
Vβ_23 | 1.4 | 0.7 | 1.4 | 1·1 | 1.1 | 1.1 |